Valuation : Illumina, Inc.

Market Cap 33.95B 29.14B 27.35B 24.98B 47.14B 3,238B 47.37B 324B 125B 1,634B 127B 125B 5,411B P/E 2026 *
45.4x
P/E 2027 * 38.4x
Enterprise Value 34.2B 29.35B 27.55B 25.16B 47.49B 3,262B 47.71B 326B 126B 1,645B 128B 126B 5,450B EV / Sales 2026 *
7.39x
EV / Sales 2027 * 6.76x
Free-Float
74.98%
Yield 2026 *
-
Yield 2027 * -
1 day+0.52%
1 week+9.68%
Current month+9.62%
1 month+15.84%
3 months+54.82%
6 months+76.48%
Current year+71.42%
1 week 208.5
Extreme 208.5
227.7
1 month 186.64
Extreme 186.64
227.7
Current year 112.65
Extreme 112.65
227.7
1 year 88
Extreme 88
227.7
3 years 68.7
Extreme 68.7
227.7
5 years 68.7
Extreme 68.7
471.1
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer 55 29/05/2025
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap.
21/08/26
Corvex Management LP
SellCompany -299,336 0.1978%
19/08/26 Other

Director

0 0%
18/08/26 Sell

Executive/Senior Manager

-1,033 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%+9.68%+127.73%+42.23% 33.95B
+0.17%+3.29%+29.73%+17.01% 234B
+0.40%+1.83%+4.42%-15.72% 151B
-0.05%-6.86%-21.90%+24.49% 131B
-1.09%-7.38%-54.72%-5.10% 69.81B
-0.22%-1.63%+11.70%+19.18% 52.33B
-0.89%-2.49%-17.74%-15.15% 50.91B
+3.60%-0.21%+31.09%+29.58% 43.8B
+1.69%-0.40%+39.86%+51.51% 40.69B
-1.08%+2.19%-17.35%+46.41% 34B
Average +0.11%+1.00%+13.28%+19.44% 84.21B
Weighted average by Cap. +0.04%+0.35%+8.78%+13.17%

Financials

2026 *2027 *
Net sales 4.62B 3.97B 3.73B 3.4B 6.42B 441B 6.45B 44.09B 17.09B 223B 17.36B 16.99B 737B 4.91B 4.22B 3.96B 3.61B 6.82B 468B 6.85B 46.82B 18.14B 236B 18.44B 18.04B 783B
Net income 760M 653M 613M 559M 1.06B 72.52B 1.06B 7.25B 2.81B 36.59B 2.85B 2.79B 121B 891M 765M 718M 656M 1.24B 85B 1.24B 8.5B 3.29B 42.88B 3.35B 3.27B 142B
Net Debt 246M 211M 198M 181M 342M 23.47B 343M 2.35B 909M 11.84B 924M 904M 39.21B -729M -626M -587M -536M -1.01B -69.53B -1.02B -6.95B -2.69B -35.08B -2.74B -2.68B -116B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
27/08/26 $230.60 +2.56% 499,433
26/08/26 $224.84 -0.07% 1,714,494
25/08/26 $224.99 +0.79% 1,918,113
24/08/26 $223.22 +1.74% 2,250,988
21/08/26 $219.40 +2.89% 1,917,222
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
224.84USD
Average target price
198.89USD
Spread / Average Target
-11.54%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock